Search results
Results From The WOW.Com Content Network
Oxycodone is a Class A drug under the Misuse of Drugs Act 1971. [166] For Class A drugs, which are "considered to be the most likely to cause harm", possession without a prescription is punishable by up to seven years in prison, an unlimited fine, or both. [167]
List of Schedule III controlled substances (U.S.) This is the list of Schedule III controlled substances in the United States as defined by the Controlled Substances Act at 21 U.S.C. § 812 (c) and 21 CFR 1308.13. The following findings are required for substances to be placed in this schedule: [ 1]
This is the list of Schedule II controlled substances in the United States as defined by the Controlled Substances Act. [ 1] The following findings are required for substances to be placed in this schedule: [ 2] The drug or other substance has a high potential for abuse. The drug or other substance has a currently accepted medical use in ...
Oxycodone/paracetamol, sold under the brand name Percocet among others, is a fixed-dose combination of the opioid oxycodone with paracetamol (acetaminophen), used to treat moderate to severe pain. [1] In 2021, it was the 75th most commonly prescribed medication in the United States, with more than 8 million prescriptions. [2] [3]
Carisoprodol. Carisoprodol, sold under the brand name Soma among others, is a medication used for musculoskeletal pain. [ 6] Effects generally begin within half an hour and last for up to six hours. [ 6] It is taken orally ( by mouth ). [ 6] Common side effects include headache, dizziness, and sleepiness. [ 6]
Oxycodone/aspirin (trade name Percodan) is a combination drug marketed by Endo Pharmaceuticals. It is a tablet containing a mixture of 325 mg (5 grains ) of aspirin and 4.8355 mg of oxycodone HCl (equivalent to 4.3346 mg of oxycodone as the free base); it is an opioid/non-opioid combination used to treat moderate to moderately severe pain. [ 1 ]
Oxymorphone (sold under the brand names Numorphan and Opana among others) is a highly potent opioid analgesic indicated for treatment of severe pain. Pain relief after injection begins after about 5–10 minutes, after oral administration it begins after about 30 minutes, and lasts about 3–4 hours for immediate-release tablets and 12 hours for extended-release tablets. [6]
Approved indication for dihydrocodeine is the management of moderate to moderately severe pain as well as coughing and shortness of breath. As is the case with other drugs in this group, the antitussive dose tends to be less than the analgesic dose, and dihydrocodeine is a powerful cough suppressant like all other members of the immediate codeine family (see below) and their cousins ...